Literature DB >> 6217004

Increase of IgA specific helper T alpha cells in patients with IgA nephropathy.

H Sakai, M Endoh, Y Tomino, Y Nomoto.   

Abstract

Patients with IgA nephropathy show an emergence of IgA dominant circulating immune complexes (CIC) as well as increased levels of serum IgA and/or IgA bearing peripheral blood lymphocytes. In order to elucidate immunological aberrations responsible for the increased IgA synthesis in such patients, quantitative and qualitative analysis was performed on T alpha cells which have been recently identified as possessing IgA specific helper activity on human B cells. Three different methods were employed to quantitate T alpha cells. These methods included a rosette formation of T cells with either bovine red cells coated with the IgA fraction of anti-bovine red cell antiserum or those coated with TNP and anti-TNP IgA antibody, and an analysis of T cells combined with fluorescein conjugated human IgA myeloma protein. T alpha cells were sorted by a fluorescence activated cell sorter and co-cultured with a B cell rich fraction to evaluate whether there is a qualitative difference in IgA specific helper activity between patients and healthy adults. T alpha cells were significantly increased in patients with IgA nephropathy while there were no significant changes in patients with chronic proliferative glomerulonephritis without mesangial deposition of IgA. There was no qualitative difference in IgA specific helper activity of T alpha cells between patients and healthy adults. It is suggested that increased levels of T alpha cells in patients with IgA nephropathy may be responsible for increased synthesis of IgA in such patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6217004      PMCID: PMC1536872     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Expression of a receptor for IgM by human T cells in vitro.

Authors:  L Moretta; M Ferrarini; M L Durante; M C Mingari
Journal:  Eur J Immunol       Date:  1975-08       Impact factor: 5.532

2.  A receptor for IgA on human T lymphocytes.

Authors:  L G Lum; A V Muchmore; D Keren; J Decker; I Koski; W Strober; R M Blaese
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

3.  Increase of IgA-bearing lymphocytes in peripheral blood from patients with IgA nephropathy.

Authors:  Y Nomoto; H Sakai; S Arimori
Journal:  Am J Clin Pathol       Date:  1979-02       Impact factor: 2.493

Review 4.  IgA-Associated glomerulonepbritis.

Authors:  D C Lowance; J D Mullins; J J McPhaul
Journal:  Int Rev Exp Pathol       Date:  1977

5.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  An extension of the 51Cr-release assay for the estimation of mouse cytotoxins.

Authors:  W Boyle
Journal:  Transplantation       Date:  1968-09       Impact factor: 4.939

7.  A subpopulation of normal human peripheral B lymphcytes that bind IgE.

Authors:  A Gonzalez-Molina; H L Spiegelberg
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

8.  IgA and glomerular disease.

Authors:  J A Whitworth; S Leibowitz; M C Kennedy; J S Cameron; C Chantler
Journal:  Clin Nephrol       Date:  1976-01       Impact factor: 0.975

9.  Interaction of aggregated -globulin with B lymphocytes.

Authors:  H B Dickler; H G Kunkel
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

10.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  19 in total

1.  Immune response of tonsillar lymphocytes to Haemophilus parainfluenzae in patients with IgA nephropathy.

Authors:  S Suzuki; S Fujieda; H Sunaga; H Sugimoto; C Yamamoto; H Kimura; T Abo; F Gejyo
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  Immune response to oral polio vaccine in patients with IgA glomerulonephritis.

Authors:  P O Leinikki; J Mustonen; A Pasternack
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

3.  Increase of IgA-specific switch T cells in patients with IgA nephropathy.

Authors:  H Sakai; M Miyazaki; M Endoh; Y Nomoto
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

4.  T-cell epitopes recognized within the 65,000 MW hsp in patients with IgA nephropathy.

Authors:  K Warr; F Fortune; S Namie; A Wilson; T Shinnick; R Van der Zee; G Williams; T Lehner
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

5.  IgA polyspecific autoantibodies in IgA nephropathy.

Authors:  P Matsiota; P Dosquet; H Louzir; E Druet; P Druet; S Avrameas
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

Review 6.  Regulation of IgA synthesis and immune response by T cells and interleukins.

Authors:  J R McGhee; J Mestecky; C O Elson; H Kiyono
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

7.  Antibodies to viruses of the herpes group in glomerulonephritis of membranous, membranoproliferative and IgA types.

Authors:  M Uj; G Szücs; J Nagy; C Trinn
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

Review 8.  IgA nephropathy in children and adults.

Authors:  N Yoshikawa; H Nakamura; H Ito
Journal:  Springer Semin Immunopathol       Date:  1994

9.  Serum IgG subclasses and IgM imbalances in adult IgA mesangial glomerulonephritis and idiopathic Henoch-Schoenlein purpura.

Authors:  G Rostoker; M A Pech; S Del Prato; M Petit-Phar; A Ben Maadi; J M Dubert; P Lang; B Weil; G Lagrue
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

10.  IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis.

Authors:  R Coppo; B Basolo; G Piccoli; G Mazzucco; M R Bulzomì; D Roccatello; M De Marchi; A O Carbonara; G Barbiano di Belgiojoso
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.